O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
-2.08%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$10.7B
AUM Growth
+$10.7B
(-6.6%)
Cap. Flow
+$450M
Cap. Flow
% of AUM
4.22%
Top 10 Holdings %
Top 10 Hldgs %
33.33%
Holding
184
New
34
Increased
39
Reduced
24
Closed
28
Top Buys
| 1 |
Edgewise Therapeutics
EWTX
|
$453M |
| 2 |
GRCL
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
|
$121M |
| 3 |
Haemonetics
HAE
|
$94.6M |
| 4 |
Terns Pharmaceuticals
TERN
|
$83.4M |
| 5 |
IMA
ImageneBio, Inc. Common Stock
IMA
|
$82.9M |
Top Sells
| 1 |
PRVL
Prevail Therapeutics Inc. Common Stock
PRVL
|
$319M |
| 2 |
Prelude Therapeutics
PRLD
|
$241M |
| 3 |
Pfizer
PFE
|
$133M |
| 4 |
Biogen
BIIB
|
$125M |
| 5 |
Centene
CNC
|
$120M |
Sector Composition
| 1 | Healthcare | 95.15% |
| 2 | Technology | 0.12% |
| 3 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
176
Cogent Biosciences
COGT
$1.83B
| – | – |
-655,000
| Closed | -$7.36M |
|
177
CEL-SCI Corp
CVM
$81.4M
| – | – |
0
| – | – |
|
178
eHealth
EHTH
$126M
| – | – |
-844,046
| Closed | -$59.6M |
|
179
Eledon Pharmaceuticals
ELDN
$155M
| – | – |
-73,650
| Closed | -$1.11M |
|
180
ESSA Pharma
EPIX
$11.2M
| – | – |
-460,500
| Closed | -$5.49M |
|
181
4D Molecular Therapeutics
FDMT
$302M
| – | – |
-125,000
| Closed | -$5.18M |
|
182
Heron Therapeutics
HRTX
$204M
| – | – |
-1,191,846
| Closed | -$25.2M |
|
|
INZY
183
DELISTED
Inozyme Pharma
INZY
| – | – |
-400,400
| Closed | -$8.26M |
|